You are here » Home » Companies » Company Overview » Wanbury Ltd

Wanbury Ltd.

BSE: 524212 Sector: Health care
NSE: WANBURY ISIN Code: INE107F01022
BSE 00:00 | 24 Apr Wanbury Ltd
NSE 05:30 | 01 Jan Wanbury Ltd
OPEN 21.90
PREVIOUS CLOSE 23.00
VOLUME 3482
52-Week high 33.35
52-Week low 10.90
P/E
Mkt Cap.(Rs cr) 55
Buy Price 22.00
Buy Qty 42.00
Sell Price 24.15
Sell Qty 100.00
OPEN 21.90
CLOSE 23.00
VOLUME 3482
52-Week high 33.35
52-Week low 10.90
P/E
Mkt Cap.(Rs cr) 55
Buy Price 22.00
Buy Qty 42.00
Sell Price 24.15
Sell Qty 100.00

Wanbury Ltd. (WANBURY) - Company History

Wanbury Ltd is the fastest growing pharma company with a Compounded Annual Growth Rate(CAGR) of 68% over the last 6 years.The company has strong presence in domestic formulations,Active Pharmaceutical Ingredient(API) and Contract Research and manufacturing Services(CRAMS).The company also has its presence in Europe in formulations. Wanbury was incorporated as Pearl Distributors Pvt Ltd in 1990.It went public and was renamed as Pearl Organics Ltd in 1991.The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs.In 1995,Pearl Organics acquired plant of Brij Chemicals Pvt Ltd at Patalganga.In 1996,the company has entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US. In 2007,Pharmaceutical Products India Ltd was amalgamated with the company pursuant to the BIFR order.In the same year, Doctor's Organics and Chemicals Ltd also came into the fold of Wanbury as this also merged with Wanbury.The company has entered into a strategic association with Bravo Healthcare Ltd and also incorporated Ningxia Wanbury Fine Chemicals Co Ltd to source raw materials from China.The company has opened its office in Zurich,Switzerland for its CRAMS business and incorporated Wanbury Global FZE in Middle East for carrying out its trading activities in the year 2008.